Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Pfizer
Merck
JNJ
Novartis
AbbVie
Roche
AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression
Fierce Pharma
Mon, 12/19/22 - 10:05 pm
AbbVie
Vraylar
depression
FDA
AbbVie leaves PhRMA, BIO: reports
Medical Marketing and Media
Thu, 12/15/22 - 11:20 pm
AbbVie
BIO
PhRMA
lobbying
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
Fierce Biotech
Wed, 12/14/22 - 10:44 am
Exicure
AbbVie
Ipsen
R&D
AbbVie slapped with age discrimination lawsuit, following other pharmas
Endpoints
Mon, 12/12/22 - 10:31 am
AbbVie
age discrimination
legal
ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle
Fierce Pharma
Mon, 12/12/22 - 10:21 am
Roche
ASH 2022
AbbVie
Regeneron
lymphoma
Lunsumio
glofitamab
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
BioSpace
Tue, 12/6/22 - 10:42 am
AbbVie
HotSpot Therapeutics
drug discovery
drug development
autoimmune disease
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Bristol Myers Squibb
AbbVie
Zeposia
Skyrizi
ulcerative colitis
Crohn's Disease
gastroentrologists
10 Massachusetts Biopharma Companies Hiring Now
BioSpace
Fri, 12/2/22 - 11:18 am
Massachusetts
hirings
AbbVie
Moderna Therapeutics
CSL
Intellia Therapeutics
Schrödinger
Visterra
Alloy Therapeutics
Werewolf Therapeutics
Sherlock Biosciences
AbbVie links up with London VC firm to map out new anti-inflammatory companies
Fierce Biotech
Tue, 11/29/22 - 10:42 am
AbbVie
venture capital
London
Deep Science Ventures
inflammatory diseases
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Fierce Pharma
Sat, 11/26/22 - 07:11 pm
Teva Pharmaceutical
AbbVie
Allergan
opioids
legal
opioid crisis
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
Fierce Biotech
Mon, 11/21/22 - 10:12 am
AbbVie
Genmab
FDA
Roche
epcoritamab
bispecific antibodies
relapsed or refractory large B-cell lymphoma
Optum to add biosimilars to formulary to tackle the massive cost of Humira
Fierce Healthcare
Wed, 11/16/22 - 11:16 pm
OptumRx
AbbVie
Humira
biosimilars
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
Fierce Pharma
Tue, 11/15/22 - 06:37 pm
legal
AbbVie
Namenda
Alzheimer's disease
pay-for-delay
Allergan
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
biotech
biopharma
employers
corporate culture
Moderna Therapeutics
Genentech
Pfizer
Amgen
AbbVie
AbbVie Touts Subgroup Data in Phase II Atrial Fibrillation Miss
BioSpace
Tue, 11/8/22 - 11:04 am
AbbVie
AGN-151607
atrial fibrillation
clinicla trials
This Biopharma Offspring Is All Grown Up
Medical Devices and Diagnostics Industry
Tue, 11/8/22 - 12:02 pm
Abbott Labs
spinoffs
AbbVie
AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq
BioSpace
Tue, 11/1/22 - 11:04 am
AbbVie
cedirogant
Skyrizi
Rinvoq
Humira
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
Mon, 10/31/22 - 04:22 pm
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »